Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $26.0600 (1.28%) ($25.4700 - $26.2400) on Sat. Sep. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.23% (three month average) | RSI | 37 | Latest Price | $26.0600(1.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.3% a day on average for past five trading days. | Weekly Trend | HALO declines -2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting HALO price | HALO will decline at least -1.115% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.115% (StdDev 2.23%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $20.34(-21.95%) | Resistance Level | $27.42 | 5 Day Moving Average | $26.17(-0.42%) | 10 Day Moving Average | $26.93(-3.23%) | 20 Day Moving Average | $27.42(-4.96%) | To recent high | -12% | To recent low | 5.2% | Market Cap | $N/A | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |